Also trades as: MYX.AX (ASX) · $vol 1M
MAYNF OTC
Mayne Pharma Group Limited
1W: -9.9%
1M: -14.9%
3M: +21.2%
YTD: -3.4%
1Y: -41.2%
3Y: -15.6%
5Y: +676.7%
$2.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$908M
-10.5% ▼
5Y CAGR: -9.1%
Total Liabilities
$518M
-19.6% ▼
5Y CAGR: -5.6%
Shareholders Equity
$390M
+5.4% ▲
5Y CAGR: -12.7%
Cash & Investments
$82M
-18.2% ▼
5Y CAGR: -3.5%
Total Debt
$43M
+4.5% ▲
5Y CAGR: -34.1%
Net Debt
-$39M
-110.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $97M | $102M | $110M | $60M | $82M |
| Short-Term Investments | $1M | $128M | $39M | $41M | $0 |
| Cash & ST Investments | $98M | $220M | $149M | $100M | $82M |
| Net Receivables | $268M | $195M | $193M | $165M | $175M |
| Inventory | $109M | $83M | $75M | $51M | $55M |
| Other Current Assets | $25M | $43M | $24M | $21M | $2M |
| Total Current Assets | $512M | $554M | $461M | $353M | $339M |
| Property, Plant & Equip. | $226M | $51M | $53M | $59M | $55M |
| Goodwill & Intangibles | $428M | $569M | $569M | $542M | $462M |
| Long-Term Investments | $0 | $0 | $15M | $0 | $0 |
| Other Non-Current Assets | $4M | $2M | $45M | $61M | $15M |
| Total Non-Current Assets | $776M | $695M | $683M | $662M | $569M |
| Total Assets | $1.3B | $1.2B | $1.1B | $1.0B | $908M |
| — Liabilities — | |||||
| Accounts Payable | $64M | $32M | $21M | $30M | $25M |
| Short-Term Debt | $405M | $11M | $32M | $35M | $42M |
| Deferred Revenue | $121M | $8M | $7M | $0 | $0 |
| Other Current Liabilities | $18M | $61M | $71M | $52M | $182M |
| Total Current Liabilities | $610M | $311M | $314M | $261M | $260M |
| Long-Term Debt | $0 | $28M | $32M | $0 | $0 |
| Other Non-Current Liab. | $109M | $261M | $333M | $381M | $252M |
| Total Non-Current Liabilities | $120M | $303M | $375M | $383M | $258M |
| Total Liabilities | $731M | $614M | $689M | $644M | $518M |
| — Equity — | |||||
| Common Stock | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Retained Earnings | -$822M | -$770M | -$944M | -$1.0B | -$1.0B |
| Accumulated OCI | $149M | $170M | $174M | $185M | $177M |
| Total Stockholders Equity | $565M | $634M | $454M | $370M | $390M |
| Total Liabilities & Equity | $1.3B | $1.2B | $1.1B | $1.0B | $908M |
| — Key Metrics — | |||||
| Total Debt | $414M | $48M | $70M | $41M | $43M |
| Net Debt | $317M | -$54M | -$40M | -$19M | -$39M |
| Total Investments | $1M | $128M | $55M | $41M | $0 |